A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine.
Saved in:
| Title: | A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine. |
|---|---|
| Authors: | Latzer P; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Zelba H; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Battke F; CeGaT GmbH, Tübingen, Germany., Reinhardt A; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Shao B; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Bartsch O; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Rabsteyn A; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Harter J; CeGaT GmbH, Tübingen, Germany., Schulze M; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Okech T; MVZ Zentrum für ambulante Onkologie GmbH, Tübingen, Germany., Golf A; MVZ Zentrum für ambulante Onkologie GmbH, Tübingen, Germany., Kyzirakos-Feger C; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Kayser S; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Pieper N; Zentrum für Humangenetik Tübingen, Tübingen, Germany., Feldhahn M; CeGaT GmbH, Tübingen, Germany., Wünsche J; Zentrum für Humangenetik Tübingen, Tübingen, Germany.; MVZ Zentrum für ambulante Onkologie GmbH, Tübingen, Germany., Seitz C; Universitätsklinikum Heidelberg, KiTZ, Hopp Children's Cancer Center, Heidelberg, Germany., Hadaschik D; CeCaVa GmbH, Tübingen, Germany., Garbe C; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany., Hauser TK; Department für Radiologie, Universitätsklinikum Tübingen, Tübingen, Germany., la Fougère C; Nuklearmedizin und Klinische Molekulare Bildgebung, Universitätsklinikum Tübingen, Tübingen, Germany., Biskup D; CeGaT GmbH, Tübingen, Germany., Brooke D; Provenance Precision Medicine Foundation, Wilmette, IL, USA., Parker D; PHM, Los Angeles, CA, USA., Martens UM; Department of Hematology and Oncology, Cancer Center Heilbronn-Franken, SLK Kliniken GmbH, Heilbronn, Germany., Illerhaus G; Klinikum Stuttgart, Stuttgart, Germany., Blumenthal DT; Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel Aviv, Israel., Merrell R; Vanderbilt University Medical Center, Nashville, TN, USA., Lorenzo LS; Clínica Universidad de Navarra, Madrid, Spain., Hidvégi M; Jewish Theological Seminary-University of Jewish Studies (OR-ZSE), Budapest, Hungary., de Robles P; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.; Tom Baker Cancer Centre, Calgary, AB, Canada., Kebir S; Universitätsklinikum Essen, Essen, Germany., Li WW; Angiogenesis Foundation, Cambridge, MA, USA., Li VW; Angiogenesis Foundation, Cambridge, MA, USA.; Harvard Medical School Dermatology, Boston, MA, USA., Williams M; NHS London, London, UK., Miller AM; Brain and Spine Tumor Center, NYU Langone Health's Perlmutter Cancer Center, New York, NY, USA., Kesari S; Pacific Neuroscience Institute, Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Castro M; Cellworks Group Inc, South San Francisco, CA, USA.; Personalized Cancer Medicine, PLLC, Santa Monica, CA, USA., Desjardins A; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Ashley DM; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Preston Robert Tisch Brain Tumor Centre, Duke University, Durham, NC, USA., Friedman HS; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Neil EC; Department of Neurology, University of Minnesota Health, Minneapolis, MN, USA., Iwamoto FM; Columbia University Medical Center, New York, NY, USA., Sipos B; BAG für Pathologie und Molekularpathologie Stuttgart, Molekularpathologie Baden-Württemberg GbR, Stuttgart, Germany., Geletneky K; Klinikum Darmstadt GmbH, Darmstadt, Germany., Zender L; University Hospital Tübingen, Internal Medicine VIII, Tübingen, Germany., Glas M; Division of Clinical Neurooncology, Department of Neurology, Universitätsklinikum Essen Klinik für Neurologie, Essen, Germany., Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Biskup S; Zentrum für Humangenetik Tübingen, Tübingen, Germany. Saskia.Biskup@humangenetik-tuebingen.de.; CeGaT GmbH, Tübingen, Germany. Saskia.Biskup@humangenetik-tuebingen.de. |
| Source: | Nature communications [Nat Commun] 2024 Aug 11; Vol. 15 (1), pp. 6870. Date of Electronic Publication: 2024 Aug 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39127809 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Latzer+P%22">Latzer P</searchLink>; Zentrum für Humangenetik Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Zelba+H%22">Zelba H</searchLink>; Zentrum für Humangenetik Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Battke+F%22">Battke F</searchLink>; CeGaT GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Reinhardt+A%22">Reinhardt A</searchLink>; Zentrum für Humangenetik Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Shao+B%22">Shao B</searchLink>; Zentrum für Humangenetik Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bartsch+O%22">Bartsch O</searchLink>; Zentrum für Humangenetik Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Rabsteyn+A%22">Rabsteyn A</searchLink>; Zentrum für Humangenetik Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Harter+J%22">Harter J</searchLink>; CeGaT GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schulze+M%22">Schulze M</searchLink>; Zentrum für Humangenetik Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Okech+T%22">Okech T</searchLink>; MVZ Zentrum für ambulante Onkologie GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Golf+A%22">Golf A</searchLink>; MVZ Zentrum für ambulante Onkologie GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kyzirakos-Feger+C%22">Kyzirakos-Feger C</searchLink>; Zentrum für Humangenetik Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kayser+S%22">Kayser S</searchLink>; Zentrum für Humangenetik Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Pieper+N%22">Pieper N</searchLink>; Zentrum für Humangenetik Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Feldhahn+M%22">Feldhahn M</searchLink>; CeGaT GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Wünsche+J%22">Wünsche J</searchLink>; Zentrum für Humangenetik Tübingen, Tübingen, Germany.; MVZ Zentrum für ambulante Onkologie GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Seitz+C%22">Seitz C</searchLink>; Universitätsklinikum Heidelberg, KiTZ, Hopp Children's Cancer Center, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hadaschik+D%22">Hadaschik D</searchLink>; CeCaVa GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Garbe+C%22">Garbe C</searchLink>; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Hauser+TK%22">Hauser TK</searchLink>; Department für Radiologie, Universitätsklinikum Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22la+Fougère+C%22">la Fougère C</searchLink>; Nuklearmedizin und Klinische Molekulare Bildgebung, Universitätsklinikum Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Biskup+D%22">Biskup D</searchLink>; CeGaT GmbH, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Brooke+D%22">Brooke D</searchLink>; Provenance Precision Medicine Foundation, Wilmette, IL, USA.<br /><searchLink fieldCode="AU" term="%22Parker+D%22">Parker D</searchLink>; PHM, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Martens+UM%22">Martens UM</searchLink>; Department of Hematology and Oncology, Cancer Center Heilbronn-Franken, SLK Kliniken GmbH, Heilbronn, Germany.<br /><searchLink fieldCode="AU" term="%22Illerhaus+G%22">Illerhaus G</searchLink>; Klinikum Stuttgart, Stuttgart, Germany.<br /><searchLink fieldCode="AU" term="%22Blumenthal+DT%22">Blumenthal DT</searchLink>; Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Merrell+R%22">Merrell R</searchLink>; Vanderbilt University Medical Center, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Lorenzo+LS%22">Lorenzo LS</searchLink>; Clínica Universidad de Navarra, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Hidvégi+M%22">Hidvégi M</searchLink>; Jewish Theological Seminary-University of Jewish Studies (OR-ZSE), Budapest, Hungary.<br /><searchLink fieldCode="AU" term="%22de+Robles+P%22">de Robles P</searchLink>; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.; Tom Baker Cancer Centre, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Kebir+S%22">Kebir S</searchLink>; Universitätsklinikum Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Li+WW%22">Li WW</searchLink>; Angiogenesis Foundation, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Li+VW%22">Li VW</searchLink>; Angiogenesis Foundation, Cambridge, MA, USA.; Harvard Medical School Dermatology, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Williams+M%22">Williams M</searchLink>; NHS London, London, UK.<br /><searchLink fieldCode="AU" term="%22Miller+AM%22">Miller AM</searchLink>; Brain and Spine Tumor Center, NYU Langone Health's Perlmutter Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Kesari+S%22">Kesari S</searchLink>; Pacific Neuroscience Institute, Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Castro+M%22">Castro M</searchLink>; Cellworks Group Inc, South San Francisco, CA, USA.; Personalized Cancer Medicine, PLLC, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Desjardins+A%22">Desjardins A</searchLink>; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ashley+DM%22">Ashley DM</searchLink>; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.; Preston Robert Tisch Brain Tumor Centre, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Friedman+HS%22">Friedman HS</searchLink>; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Wen+PY%22">Wen PY</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Neil+EC%22">Neil EC</searchLink>; Department of Neurology, University of Minnesota Health, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Iwamoto+FM%22">Iwamoto FM</searchLink>; Columbia University Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Sipos+B%22">Sipos B</searchLink>; BAG für Pathologie und Molekularpathologie Stuttgart, Molekularpathologie Baden-Württemberg GbR, Stuttgart, Germany.<br /><searchLink fieldCode="AU" term="%22Geletneky+K%22">Geletneky K</searchLink>; Klinikum Darmstadt GmbH, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Zender+L%22">Zender L</searchLink>; University Hospital Tübingen, Internal Medicine VIII, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Glas+M%22">Glas M</searchLink>; Division of Clinical Neurooncology, Department of Neurology, Universitätsklinikum Essen Klinik für Neurologie, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Reardon+DA%22">Reardon DA</searchLink>; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Biskup+S%22">Biskup S</searchLink>; Zentrum für Humangenetik Tübingen, Tübingen, Germany. Saskia.Biskup@humangenetik-tuebingen.de.; CeGaT GmbH, Tübingen, Germany. Saskia.Biskup@humangenetik-tuebingen.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Aug 11; Vol. 15 (1), pp. 6870. <i>Date of Electronic Publication: </i>2024 Aug 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39127809 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-024-51315-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 6870 Titles: – TitleFull: A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Latzer P – PersonEntity: Name: NameFull: Zelba H – PersonEntity: Name: NameFull: Battke F – PersonEntity: Name: NameFull: Reinhardt A – PersonEntity: Name: NameFull: Shao B – PersonEntity: Name: NameFull: Bartsch O – PersonEntity: Name: NameFull: Rabsteyn A – PersonEntity: Name: NameFull: Harter J – PersonEntity: Name: NameFull: Schulze M – PersonEntity: Name: NameFull: Okech T – PersonEntity: Name: NameFull: Golf A – PersonEntity: Name: NameFull: Kyzirakos-Feger C – PersonEntity: Name: NameFull: Kayser S – PersonEntity: Name: NameFull: Pieper N – PersonEntity: Name: NameFull: Feldhahn M – PersonEntity: Name: NameFull: Wünsche J – PersonEntity: Name: NameFull: Seitz C – PersonEntity: Name: NameFull: Hadaschik D – PersonEntity: Name: NameFull: Garbe C – PersonEntity: Name: NameFull: Hauser TK – PersonEntity: Name: NameFull: la Fougère C – PersonEntity: Name: NameFull: Biskup D – PersonEntity: Name: NameFull: Brooke D – PersonEntity: Name: NameFull: Parker D – PersonEntity: Name: NameFull: Martens UM – PersonEntity: Name: NameFull: Illerhaus G – PersonEntity: Name: NameFull: Blumenthal DT – PersonEntity: Name: NameFull: Merrell R – PersonEntity: Name: NameFull: Lorenzo LS – PersonEntity: Name: NameFull: Hidvégi M – PersonEntity: Name: NameFull: de Robles P – PersonEntity: Name: NameFull: Kebir S – PersonEntity: Name: NameFull: Li WW – PersonEntity: Name: NameFull: Li VW – PersonEntity: Name: NameFull: Williams M – PersonEntity: Name: NameFull: Miller AM – PersonEntity: Name: NameFull: Kesari S – PersonEntity: Name: NameFull: Castro M – PersonEntity: Name: NameFull: Desjardins A – PersonEntity: Name: NameFull: Ashley DM – PersonEntity: Name: NameFull: Friedman HS – PersonEntity: Name: NameFull: Wen PY – PersonEntity: Name: NameFull: Neil EC – PersonEntity: Name: NameFull: Iwamoto FM – PersonEntity: Name: NameFull: Sipos B – PersonEntity: Name: NameFull: Geletneky K – PersonEntity: Name: NameFull: Zender L – PersonEntity: Name: NameFull: Glas M – PersonEntity: Name: NameFull: Reardon DA – PersonEntity: Name: NameFull: Biskup S IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 08 Text: 2024 Aug 11 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |